Basilea Pharmaceutica
BSLN.SW
#6318
Rank
C$0.87 B
Marketcap
$72.27
Share price
0.00%
Change (1 day)
18.54%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2023: C$17.25 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are C$0.18 Billion. In 2023 the company made an earning of C$17.25 Million a decrease over its 2022 earnings that were of C$18.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2023

Annual earnings

Year Earnings Change
2023C$17.25 M-5.02%
2022C$18.17 M-276.18%
2021-C$10.32 Million-55.31%
2020-C$23.08 Million-28%
2019-C$32.06 Million-27.06%
2018-C$43.95 Million62.13%
2017-C$27.11 Million-60.94%
2016-C$69.39 Million-19.67%
2015-C$86.38 Million48.25%
2014-C$58.27 Million12.95%
2013-C$51.59 Million-35.16%
2012-C$79.56 Million-5.75%
2011-C$84.42 Million-152.57%
2010C$0.16 B-199.59%
2009-C$0.17 Billion-15.54%
2008-C$0.2 Billion22.84%
2007-C$0.16 Billion60.07%
2006-C$97.09 Million85.69%
2005-C$52.29 Million-43.04%
2004-C$91.8 Million47.04%
2003-C$62.43 Million-34.82%
2002-C$95.78 Million